Q/C Technologies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell QCLS and other ETFs, options, and stocks.About QCLS
Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms.
CEOChristopher C. Chapman, Jr., MD
CEOChristopher C. Chapman, Jr., MD
Employees2
Employees2
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded1989
Founded1989
Employees2
Employees2
QCLS Key Statistics
Market cap7.34M
Market cap7.34M
Price-Earnings ratio-0.02
Price-Earnings ratio-0.02
Dividend yield—
Dividend yield—
Average volume6.57M
Average volume6.57M
High today$4.64
High today$4.64
Low today$3.81
Low today$3.81
Open price$4.39
Open price$4.39
Volume581.95K
Volume581.95K
52 Week high$195.00
52 Week high$195.00
52 Week low$3.24
52 Week low$3.24
QCLS News
TipRanks 5d
TNF Pharmaceuticals changes name to Q/C TechnologiesTNF Pharmaceuticals announced that it has changed its corporate name to Q/C Technologies and will begin trading under the new ticker symbol (QCLS) on Nasdaq, ef...
People also own
Based on the portfolios of people who own QCLS. This list is generated using Robinhood data, and it’s not a recommendation.